Are Novel Immunotherapy Combos Effective for Indolent Lymphoma Care?ByLorenzo Falchi, MDSeptember 29th 2025Bispecific antibodies have demonstrated adaptability and versatility when combined with immunotherapy and chemotherapy agents.